Estradiol (E2)
Estradiol is the main estrogen in premenopausal women and is also produced in smaller amounts in men through aromatization of testosterone. In women it regulates menstrual cycles, reproductive tissues, bone density, and mood; in men excess estradiol can cause gynecomastia and suppress testosterone. Levels vary widely across the menstrual cycle and with menopause. Measured in both sexes - see reference ranges for sex-specific values.
Units: pg/mL; some labs report pmol/L (pmol/L = pg/mL × 3.67). Check the units on your report before comparing to any range here.
Optimal range: who says what
Institutions, researchers and practitioners draw the line in different places. Each position is listed with who holds it and, where a document states it, a link. How we verify ranges.
- Named practitionermen 16-29 pg/mL (LC/MS)Life Extension · Lab Testing Protocol (Suggested Optimal Ranges)Disclosure: Life Extension sells lab panels that appear in our blood-test comparisons.
- Lab reference intervalMen: 10-40 pg/mL, Women vary by cycle phaseWhat a lab report flags against. A lab interval is not an optimal target.
Practitioner targets are individual positions, often tighter than guideline ranges. Each was checked against its article before publishing.
17 of 21 itemized panels
Sex Hormones (Female)
What is Estradiol (E2)?
Estradiol (E2) is the most potent and predominant form of estrogen in the body, and it's critically important for BOTH men and women. In women, it's produced primarily by the ovaries and drives sexual development, menstrual cycle regulation, bone health, cardiovascular protection, cognitive function, and more. In men, estradiol is produced by aromatization of testosterone in fat tissue and other organs, and it's essential for bone density, libido, cardiovascular health, and brain function.
Estradiol isn't just a "female hormone," and testosterone isn't just a "male hormone." Men need estradiol for optimal bone density and cardiovascular health—too low is as problematic as too high. Similarly, women need testosterone for muscle mass, libido, and energy. The key is balance. In men on testosterone replacement therapy (TRT), excessive aromatization can elevate estradiol, causing gynecomastia (breast development), water retention, and mood issues. Conversely, blocking estradiol too aggressively with aromatase inhibitors can harm bone density and lipid profile.
Estradiol levels vary dramatically across the menstrual cycle in premenopausal women (low in follicular phase, peak at ovulation, moderate in luteal phase) and plummet after menopause. Postmenopausal women have estradiol levels similar to men unless on hormone replacement therapy (HRT). Optimal estradiol levels are context-dependent: cycling women should be tested on specific cycle days, while men and postmenopausal women have static targets.
Why Estradiol Matters for Longevity (Men and Women)
- Bone density: Estradiol is THE most important hormone for maintaining bone mineral density in both sexes. Low estradiol = accelerated osteoporosis.
- Cardiovascular protection: Estradiol improves endothelial function, raises HDL, lowers LDL, and reduces arterial stiffness (premenopausal women have lower CVD risk than men).
- Brain health: Estradiol supports cognitive function, memory, mood, and may protect against Alzheimer's disease. Estradiol decline at menopause linked to cognitive decline.
- Libido and sexual function: Optimal estradiol supports libido in both sexes. Too low OR too high impairs sexual function in men.
- Metabolic health: Estradiol improves insulin sensitivity and body composition. Loss at menopause drives visceral fat accumulation.
- Skin and connective tissue: Estradiol maintains skin thickness, collagen, and elasticity.
Interpretation bands (curated, PMID-backed)
Holder: OptimizeBiomarkers editorial synthesis of: Vascular Effects of Early versus Late Postmenopausal Treatment with Estradiol (Hodis et al., 2016); Estradiol-based postmenopausal hormone therapy and risk of cardiovascular and all-cause mortality (Mikkola et al., 2015). No single paper sets these cutoffs; for attributed targets see who says what.
Optimal (Men)20-40 pg/mL▼
- Sweet spot for men
- Higher levels (>50 pg/mL) may cause gynecomastia, water retention, mood issues
- Lower levels (<20 pg/mL) harm bone density and lipids
Optimal (Premenopausal Women - Follicular)30-100 pg/mL▼
- Early follicular phase (days 1-7 of cycle)
- Estradiol is low after menstruation, then rises
Optimal (Premenopausal Women - Ovulation)100-400 pg/mL▼
- Midcycle (days 12-16)
- Estradiol peaks at ovulation to trigger LH surge
Optimal (Premenopausal Women - Luteal)80-200 pg/mL▼
- Luteal phase (days 17-28)
- Estradiol is moderate; progesterone dominates in this phase
- Vascular Effects of Early versus Late Postmenopausal Treatment with Estradiol.
- The benefits and risks of menopause hormone therapy for the cardiovascular system in postmenopausal women: a systematic review and meta-analysis.
- Estradiol-based postmenopausal hormone therapy and risk of cardiovascular and all-cause mortality.
What raises or lowers Estradiol
Causes of high Estradiol
- Obesity in men: Excess fat tissue contains aromatase enzyme, converting testosterone→estradiol.
- Excessive testosterone replacement therapy (TRT) in men: More substrate for aromatization = higher estradiol.
- Estrogen-secreting tumors: Rare ovarian or adrenal tumors (granulosa cell tumor).
- Liver disease (cirrhosis): Impaired estrogen clearance leads to accumulation.
- Hyperthyroidism: Increased SHBG and altered estrogen metabolism.
- Exogenous estrogen use: HRT, oral contraceptives, or inadvertent exposure (phytoestrogens, xenoestrogens).
- Aromatase excess syndrome (rare genetic condition).
Causes of low Estradiol
- Menopause: Ovarian follicles depleted, estradiol production drops to <30 pg/mL. Most common cause of low estradiol in women >45.
- Premature ovarian insufficiency (POI): Ovarian failure before age 40. Autoimmune, genetic (Turner syndrome), chemotherapy/radiation.
- Hypothalamic amenorrhea: Excessive exercise, low body fat, chronic stress, eating disorders suppress GnRH→LH/FSH→estradiol axis.
- Aromatase inhibitor overuse (men): Excessive AI use on TRT crashes estradiol.
- Anorexia nervosa, extreme calorie restriction: Body shuts down reproductive axis to conserve energy.
- PCOS with anovulation: Some PCOS women have low estradiol due to chronic anovulation (others have estrogen dominance).
- Pituitary or hypothalamic disorders: Tumors, trauma, Sheehan syndrome suppress LH/FSH, lowering estradiol.
Symptoms when Estradiol is high or low
When high
- Gynecomastia (breast enlargement in men)
- Water retention, bloating
- Mood swings, irritability, emotional lability
- Decreased libido, erectile dysfunction (men)
- Acne, oily skin
- Weight gain, especially hips/thighs (women)
- Breast tenderness (women)
- Increased risk of blood clots (VTE) if very high
- Migraine headaches (women)
- Heavy menstrual bleeding (premenopausal women)
- Increased cancer risk (endometrial, breast) if chronically elevated without progesterone balance
High estradiol in men >50 pg/mL often due to obesity or excessive TRT. In premenopausal women, persistently high estradiol may indicate estrogen dominance or ovarian cysts.
When low
- Low libido, decreased sexual desire (both sexes)
- Vaginal dryness, painful intercourse (women)
- Hot flashes, night sweats (postmenopausal women)
- Mood swings, depression, anxiety
- Bone loss, osteoporosis, increased fracture risk
- Fatigue, low energy
- Cognitive decline, brain fog, memory problems
- Joint pain, stiffness
- Dry skin, thinning hair
- Increased abdominal fat (postmenopausal women)
- Erectile dysfunction (men with very low E2)
Low estradiol in men <15 pg/mL harms bone density and libido. In postmenopausal women, low estradiol causes hot flashes and bone loss.
How to move Estradiol
Effect sizes (how much something moves the marker) appear only where the paper cited under the item states them. Talk to your clinician before starting or changing any medication or supplement.
Manage High Estradiol in Men (if >50 pg/mL)
- Aromatase inhibitors (AI): Anastrozole (Arimidex) 0.25-0.5 mg twice weekly reduces estradiol by blocking testosterone→estradiol conversion. Life Extension suggests 16-29 pg/mL (LC/MS) for men (see who says what above). Caution: excessive AI use crashes estradiol, harming bones and lipids.
- Weight loss: Fat tissue contains aromatase enzyme. Losing body fat reduces estradiol production.
- Reduce TRT dose: If on supraphysiologic testosterone, lowering dose reduces substrate for aromatization.
- DIM (diindolylmethane): 100-200 mg/day from cruciferous vegetables may support estrogen metabolism. Modest effect.
Hormone Replacement Therapy (HRT) for Postmenopausal Women
- Estradiol is the gold standard for menopausal symptom relief (hot flashes, vaginal dryness, mood, sleep) and prevention of bone loss and cardiovascular disease.
- Transdermal estradiol (patch or gel): 0.025-0.1 mg/day. Preferred route; avoids first-pass liver metabolism, lower VTE risk than oral.
- Oral estradiol: 0.5-2 mg/day. Convenient but increases clotting factors slightly.
- Bioidentical estradiol: Chemically identical to human estradiol (preferred over conjugated equine estrogens like Premarin).
- MUST combine with progesterone if uterus intact to prevent endometrial hyperplasia/cancer.
- Timing: Starting HRT within 10 years of menopause (<60 years old) is associated with cardiovascular benefit. Later initiation may increase risk.
Raise Low Estradiol in Men (if <20 pg/mL)
- Low estradiol in men harms bone density, lipids, and libido. Usually caused by aromatase inhibitor overuse or very low body fat.
- Reduce or stop aromatase inhibitor: If on AI, lower dose or discontinue to allow more testosterone→estradiol conversion.
- Increase testosterone dose: More testosterone substrate = more estradiol production.
- Transdermal estradiol (off-label): Rarely, exogenous low-dose estradiol (0.025 mg patch) used in men with genetic aromatase deficiency.
Optimize Estradiol in Premenopausal Women
- Most reproductive-age women have normal estradiol if ovulating regularly. Low estradiol suggests anovulation, hypothalamic amenorrhea, or premature ovarian insufficiency.
- Restore ovulation: Address excessive exercise, low body fat (<18% often suppresses ovulation), chronic stress, calorie restriction.
- Seed cycling: Controversial but some women report benefit from flaxseeds (follicular phase) and pumpkin/sesame seeds (luteal phase) to support hormonal balance.
- Consider oral contraceptives: Birth control pills provide synthetic estrogen but suppress natural estradiol production (pros and cons).
Lifestyle Support for Healthy Estrogen Balance
- Body fat: Very lean men (under about 10% body fat) and women (under about 18%) often have low estradiol due to insufficient aromatization/ovarian function. Conversely, obesity increases estradiol via excess aromatase.
- Cruciferous vegetables: Broccoli, cauliflower, kale contain DIM and I3C, which support estrogen metabolism and clearance of harmful metabolites.
- Fiber: 25-35 g/day promotes estrogen excretion via bile. Low fiber = enterohepatic recirculation of estrogen.
- Limit alcohol: Alcohol impairs estrogen clearance via liver, raising levels.
- Phytoestrogens: Soy, flaxseed contain weak plant estrogens that may modulate estradiol activity (evidence is mixed).
When to retest
- If starting or adjusting HRT (women): Retest estradiol after 3 months against the target your clinician sets for symptom relief and bone protection.
- If on TRT (men): Check estradiol along with total/free testosterone every 3-6 months. Adjust aromatase inhibitor dose if needed to keep E2 within the target your clinician sets.
- If postmenopausal and symptomatic: Baseline estradiol to assess if HRT candidate.
- If premenopausal with irregular cycles: Test estradiol on day 3 of the cycle and again on day 21 (with progesterone), and compare each result with the lab's interval for that cycle phase.
- If optimizing bone density: Retest annually along with bone markers (CTX, P1NP) and DEXA scan every 1-2 years.
Scientific Evidence
Estrogen and Bone
Estrogen is the major hormonal regulator of bone metabolism in both women and men. Losing estrogen mainly increases bone resorption, and it also opens a gap between resorption and new bone formation.
Source: Estrogen and the skeleton.
Menopausal Hormone Therapy and Mortality
In 18 years of follow-up of the two Women's Health Initiative trials (27,347 women aged 50-79), hormone therapy did not change all-cause mortality (27.1% versus 27.6%), cardiovascular mortality, or cancer mortality. During the treatment phase, women aged 50-59 fared better than women aged 70-79 (ratio of hazard ratios 0.61).
Hormone Therapy and Dementia
In the WHI Memory Study, estrogen plus progestin (CEE/MPA) increased dementia risk in women 65 and older, although observational studies had linked estrogen use to lower Alzheimer's risk. Whether hormone therapy started near menopause lowers dementia risk is unresolved. CEE/MPA worsened verbal memory; estrogen alone had no effect on cognition.
Source: Hormone therapy, dementia, and cognition: the Women's Health Initiative 10 years on.
Which Providers Test Estradiol (E2)?
Cheapest: Mito Health at $297/year. Most comprehensive: Function Health, 160+ biomarkers for $365/year.
17 panels that include it, cheapest first
| Provider | Annual Cost | Total Biomarkers | $/Biomarker |
|---|---|---|---|
| $297 | 100+ | $2.97 | |
 Superpower | $349 | 100+ | $3.49 |
| $349 | 75+ | $4.65 | |
 WHOOP Advanced Labs | $349 | 65 | $5.37 |
 Function Health | $365 | 160+ | $2.28 |
| $365 | 100+ | $3.65 | |
| $375 | 108 | $3.47 | |
| $449 | 83 | $5.41 | |
| $495 | 80+ | $6.19 | |
| $499 | 100+ | $4.99 | |
| $700 | 138 | $5.07 | |
| $829 | 54 | $15.35 | |
| $895 | 100+ | $8.95 | |
| $996 | 59 | $16.88 | |
| $1188 | 70+ | $16.97 | |
| $1198 | 40+ | $29.95 | |
| $1950 | 130+ | $15.00 |
$/Biomarker is annual cost divided by the panel's advertised biomarker count, not the price of this one test. We track 23 blood test providers (32 plans); 21 of those plans are itemized marker by marker. Compare all of them.
4 itemized panels do not include Estradiol (E2)
Labcorp OnDemand · Marek Health Base · Empirical Health · Oura Health Panels
11 providers not itemized in our matrix
We have not itemized these marker by marker (some sell tests one at a time), so this page cannot say whether they offer Estradiol (E2). Check with them directly.
Life Extension Standard · Quest Health · Ultrahuman Blood Vision · Lifeforce · Hundred Health · Personalabs · Walk-In Lab · HealthLabs · WHOOP Specialized Panels · Marek Health Essential · Vitality Blueprint Upload
Experts discussing Estradiol (E2)
Podcast episodes where clinicians and researchers cover this marker in depth. Curated by hand; an episode is listed only when the marker is a substantial topic, not a passing mention.
- Testosterone Replacement Therapy, Hormone Testing 101, and More
- Best Of Hormone Health
- How to Uncover Hidden Hormone Imbalances
- Test Your Sex Hormones & Cortisol at Home
- Bryan Johnson's Blueprint: The 11 Biomarkers for LongevityDisclosure: This is Bryan Johnson's podcast; Johnson owns Blueprint, which appears in our blood-test comparisons.
- Dr. Natalie Crawford: Female Hormone Health, Fertility & VitalityDisclosure: Huberman Lab has been sponsored by Function Health, which appears in our blood-test comparisons.
Frequently Asked Questions
What is the optimal range for Estradiol (E2)?
Named practitioners target: men 16-29 pg/mL (LC/MS) (Life Extension). Lab reference interval: Men: 10-40 pg/mL, Women vary by cycle phase. That is what a lab report flags against, not an optimal target.
Which blood test providers include Estradiol (E2)?
17 of the 21 blood testing panels we itemize marker by marker include Estradiol (E2) in their panels. This biomarker is widely available across major providers.
Related: YouBoost rates lifestyle and supplement interventions by evidence; HRV Zone tracks recovery trends.
Medical Disclaimer
This information is for educational purposes only and is not medical advice. Always consult with a qualified healthcare provider about your specific health needs.
Last reviewed Sep 23, 2026 · First published Sep 30, 2025